Effects of physical exercise during adjuvant chemotherapy for breast cancer on long-term tested and perceived cognition: results of a pragmatic follow-up study

Willeke R. Naaktgeboren,Emmie W. Koevoets,Martijn M. Stuiver,Wim H. van Harten,Neil K. Aaronson,Elsken van der Wall,Miranda Velthuis,Gabe Sonke,Sanne B. Schagen,Wim G. Groen,Anne M. May
DOI: https://doi.org/10.1007/s10549-023-07220-7
2024-01-29
Breast Cancer Research and Treatment
Abstract:Abstract Purpose Cancer-related cognitive impairment (CRCI) following chemotherapy is commonly reported in breast cancer survivors, even years after treatment. Data from preclinical studies suggest that exercise during chemotherapy may prevent or diminish cognitive problems; however, clinical data are scarce. Methods This is a pragmatic follow-up study of two original randomized trials, which compares breast cancer patients randomized to exercise during chemotherapy to non-exercise controls 8.5 years post-treatment. Cognitive outcomes include an online neuropsychological test battery and self-reported cognitive complaints. Cognitive performance was compared to normative data and expressed as age-adjusted z-scores. Results A total of 143 patients participated in the online cognitive testing. Overall, cognitive performance was mildly impaired on some, but not all, cognitive domains, with no significant differences between groups. Clinically relevant cognitive impairment was present in 25% to 40% of all participants, regardless of study group. We observed no statistically significant effect of exercise, or being physically active during chemotherapy, on long-term cognitive performance or self-reported cognition, except for the task reaction time, which favored the control group (β = -2.04, 95% confidence interval: -38.48; -2.38). We observed no significant association between self-reported higher physical activity levels during chemotherapy or at follow-up and better cognitive outcomes. Conclusion In this pragmatic follow-up study, exercising and being overall more physically active during or after adjuvant chemotherapy for breast cancer was not associated with better tested or self-reported cognitive functioning, on average, 8.5 years after treatment. Future prospective studies are needed to document the complex relationship between exercise and CRCI in cancer survivors.
oncology
What problem does this paper attempt to address?
The problem that this paper attempts to solve is to evaluate the impact of physical exercise during adjuvant chemotherapy for breast cancer on long - term cognitive function. Specifically, the researchers wanted to understand whether, among breast cancer patients receiving adjuvant chemotherapy, compared with the non - exercise control group, participation in moderate - to - high - intensity exercise interventions could significantly improve objective cognitive test results and self - reported cognitive symptoms 8.5 years after treatment. ### Research Background - **Cancer - related cognitive impairment (CRCI)**: One of the common side effects after chemotherapy. Even years after treatment, breast cancer survivors may still report cognitive impairment. - **Exercise and cognition**: Previous studies have shown that exercise during chemotherapy may prevent or alleviate cognitive problems, but there is less clinical data. ### Research Objectives - **Primary objective**: To evaluate the impact of moderate - to - high - intensity aerobic and resistance exercise interventions during adjuvant chemotherapy for breast cancer on long - term cognitive function. - **Hypothesis**: The study hypothesized that exercise during chemotherapy could reduce cognitive impairment years after treatment, compared with the routine care control group. ### Methods - **Study design**: This is a follow - up study of a randomized controlled trial, comparing the cognitive functions of breast cancer patients randomly assigned to the exercise group and the non - exercise control group during chemotherapy. - **Participants**: A total of 143 patients participated in the online cognitive test. - **Cognitive assessment**: - **Objective cognitive test**: Using the online Amsterdam Cognitive Scan (ACS) tool, covering five cognitive domains: learning and memory, attention and working memory, processing speed, executive function, and motor function. - **Subjective cognitive complaints**: Assessed by the MD Anderson Symptom Inventory (MDASI) questionnaire. ### Results - **Overall cognitive performance**: In some cognitive domains (especially learning and memory), the performance of the participants was slightly lower than that of the healthy control group, but normal in other domains. - **Comparison between groups**: No significant better performance in objective cognitive tests or self - reported cognitive function was found in the moderate - to - high - intensity exercise group compared with the control group. - **Response time for specific tasks**: The control group performed better in the response time task (β = - 2.04, 95% confidence interval: - 38.48; - 2.38). - **Long - term cognitive impairment**: Approximately 25% to 40% of the participants had clinically relevant cognitive impairment, regardless of which study group they belonged to. ### Conclusions - **Main conclusion**: In this follow - up study, moderate - to - high - intensity exercise during chemotherapy or being more active in general did not significantly improve objective or self - reported cognitive function 8.5 years after treatment. - **Future research**: More prospective studies are needed to document the complex relationship between exercise and CRCI in cancer survivors. ### Keywords - Breast cancer - Cognition - Exercise - Physical activity Through this study, the researchers hope to provide breast cancer patients with scientific evidence regarding the impact of exercise during chemotherapy on long - term cognitive function, thereby guiding clinical practice.